Yuri Matusov, MD, FACP, FCCP, ATSF

Dr Yuri Matusov holds an appointment as Assistant Professor of Medicine in the Division of Pulmonary and Critical Care Medicine at Cedars-Sinai Medical Center, in addition to a joint appointment as Health Sciences Assistant Clinical Professor at the UCLA Geffen School of Medicine. Dr. Matusov's clinical and research interests are in heart-lung interactions of pulmonary vascular disease and critical illness. He serves as the Director of the PHA-Accredited Pulmonary Hypertension Center of Comprehensive Care at Cedars-Sinai, regularly attends in the Intensive Care Unit and for the inpatient pulmonary vascular service, and is an Associate Program Director for the Pulmonary and Critical Care Fellowship. His work has been published in CHEST, Respiratory Medicine, Circulation, JACC, and Annals of Internal Medicine. Dr. Matusov completed internal medicine residency at Santa Barbara Cottage Hospital and pulmonary and critical care fellowship at Cedars-Sinai.
Financial relationships
-
Attribution:SelfType of financial relationship:In-Kind Research SupportIneligible company:United TherapeuticsTopic:Pulmonary HypertensionDate added:09/25/2026Date updated:09/25/2026
-
Attribution:SelfType of financial relationship:In-Kind Research SupportIneligible company:TenaxTopic:Pulmonary HypertensionDate added:09/25/2026Date updated:09/25/2026
-
Attribution:SelfType of financial relationship:In-Kind Research SupportIneligible company:PenumbraTopic:Pulmonary EmbolismDate added:09/25/2026Date updated:09/25/2026
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:MallinckrodtTopic:ARDSDate added:09/25/2026Date updated:09/25/2026
-
Attribution:SelfType of financial relationship:In-Kind Research SupportIneligible company:AerovateTopic:Pulmonary HypertensionDate added:09/25/2026Date updated:09/25/2026Relationship end date:01/02/2025
-
Attribution:SelfType of financial relationship:In-Kind Research SupportIneligible company:BioAegisTopic:ARDSDate added:09/25/2026Date updated:09/25/2026
-
Attribution:SelfType of financial relationship:ConsultantIneligible company:United TherapeuticsTopic:Pulmonary HypertensionDate added:09/25/2026Date updated:09/25/2026
-
Attribution:SelfType of financial relationship:ConsultantIneligible company:Jupiter EndovascularTopic:Pulmonary EmbolismDate added:09/25/2026Date updated:09/25/2026

Facebook
X
LinkedIn
Forward